Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



Set Alert for People

NuVasive Replaces CFO In Wake Of Poor Q2

Spine firm NuVasive has named Rajesh Asarpota as the company's new executive vice president and chief financial officer. He steps in after the previous CFO left following NuVasive's disappointing Q2 2017 results.

Appointments Medical Device

Atlantic Therapeutics Appoints Former Zeltiq CEO As Chairman

Atlantic Therapeutics has appointed former Zeltiq Aesthetics CEO Gordie Nye as its new chairman to help drive adoption of its CE-marked Innovo device for treating clinical conditions associated with pelvic floor weakness.

Appointments Gynecology & Urology

Estrampes Appointed To Helm Of GE Healthcare EU

GE Healthcare has appointed Catherine Estrampes as CEO of its European operations, replacing Jean-Michel Malbrancq who is leaving to pursue opportunities outside of GE after 35 years with the company.

Companies Appointments

EOS Imaging Appoints New US President And CFO

French ortho medical imaging specialist EOS imaging has made two new senior leadership appointments. Mike Lobinsky joins in a newly created role as US President while Pierre Schwich has been hired as the company's new CFO.

Orthopedics Appointments

AxoGen Creates New Chief Commercial Officer Role

Axogen has hired Boston Scientific alumnus Jon Gingrich to the newly created role of chief commercial officer (CCO). Gingrich will oversee development and execution of the company's sales and marketing development as it expands its portfolio of nerve regeneration products.

Appointments Regenerative Medicine

Device Week – July 14, 2017

On this week's Medtech Insight podcast: FDARA user-fee bill progresses in the US Congress; a deep-dive look into the US Open Payments database yields interesting news and trends; in an unusual step, US FDA publicly shares 483 inspection observation form after troublesome Magellan Diagnostics audit; standards organization GS1 and the Healthcare Industry Distributors Association try to solve billing headaches; top management shaken up at Zimmer Biomet.

Compliance Regulation

Zimmer Biomet Names New CEO Amid Disappointing Earnings

David Dvorak has stepped down as president and CEO, and from the company's board, and CFO Daniel P. Florin will take over as interim CEO, the orthopedics giant announced July 11. The company also announced preliminary second-quarter sales and earnings that, while within the previously projected range, included disappointments for several product lines.

Companies Sales & Earnings

Top US FDA Global Regulator Joins Major Law Firm's Health-Care Division

Howard Sklamberg, the former US FDA deputy commissioner for global regulatory operations and policy who left the agency in April, will now join the health-care practice at the law firm Akin Gump.

FDA Regulation

Acting US FDA Chief Scientist Tapped, As Borio Moves To White House Biodefense Detail

FDA promotes Denise Hinton to acting chief scientist after Luciana Borio is detailed to the National Security Council for biodefense work

FDA Policy
See All